endexxEndexx Corp., based in Phoenix, Arizona, is a company that represents its shareholders’ interest and collaborates with independent scientists, engineers, software developers, and other companies to create businesses that can collectively thrive in equity markets. Endexx Corp., formerly known as Visual Board Books, Inc., is a micro-cap publicly traded company that trades in the OTC market under the symbol EDXC.

Through its subsidiaries—m3Hub, Project Canopy, and Global Solaris Group, Endexx Corp. provides innovative medical marijuana management and technology solutions for entrepreneurs.

The individuals that comprise the Endexx Management Team and its advisory group all have anywhere from 10 to 50 years of experience in their own fields. The business professionals in charge of supervising the company’s direction are all highly knowledgeable in developing and executing new technologies, growing businesses, and operating publicly traded corporations.

The team at Endexx understands that small, independent companies with fresh technologies experience difficulty supporting themselves. They therefore collaborate so as to use both individual and group skill sets to improve technology, grow the business, eliminate redundancies, and consolidate costs simultaneously.

The m3Hub Technology platform manages patient concentric data, integrates the best patient privacy practices through verification, privacy, legal, and transparent controls, and legitimizes the whole transaction process on behalf of the patients.

The Project Canopy platform provides networks with a virtual environment where they can work together, without geographical or physical constraints, by harnessing the power of the cloud.

The Global Solaris Group is a full-service power provider and producer of turnkey Renewable Energy that is professionally engineered for optimal performance for operations that require dependable power systems, such as governments, communities, data centers, schools, churches, electric utilities, irrigation districts, agriculture areas, and mining areas.

Essentially, Endexx Corp. provides as a platform for entrepreneurs to succeed by offering them maximum return on investment via equity ownership in the parent corporation. All individuals are shareholders, and are encouraged to succeed and contribute to the ultimate goal of increasing shareholder value.


Yahoo! Finance: EDXC News

Latest Financial News for EDXC

Endexx Files Amended Form 10 Including Fiscal 2020 PCAOB Audited Financials

CAVE CREEK, AZ, April 09, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Endexx Corporation (OTC: EDXC), a lifestyle company focused on the intersection of science, compliance, and formulation of innovative phytonutrient-based skin care and nutritional products, today announced an update that it has publicly filed its fiscal 2020 PCAOB audited financials with the amended Registration Statement on Form 10 with the Securities and Exchange Commission (SEC). This is a voluntary filing that is subject to SEC review. If the Registration Statement becomes effective, it would designate Endexx as an SEC reporting company and register its shares pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended. Additionally, if the Registration Statement becomes effective, private and accredited investors who purchased or purchase shares in the Company through private placement would have adjusted holding periods for registration, as the statutory holding period of private placement shares would be reduced, under Rule 144 of the Securities Act of 1933, as amended (the Securities Act). Endexx currently publishes quarterly and annual reports as well as PCAOB audited financial statements, and is in compliance with OTC Markets Alternative Reporting Standard (ARS). Should the Registration Statement become effective, Endexx would file these reports and financial statements as 10-Qs and 10-Ks with the SEC, along with current reports on Form 8-K, in addition to complying with all other obligations under the Exchange Act. See Filing: https://sec.report/Document/0001493152-21-008293/?fbclid=IwAR1-TK6-2fkumN7E52pumS8VMp2jhjPi-yssHq0yAN30Z4QrP4L1qtfFgVA About Endexx Corporation Endexx Corporation, through its operating division CBD Unlimited, develops and distributes all-natural CBD products derived from cannabis sativa plant (Hemp), containing less than 0.01% THC. Its products range from oils, capsules, topicals, and pet products, all with the shared purpose of therapeutic and pain relief for humans and pets. Phyto-Bites are CBD soft chews for animal use that are formulated to promote health and support the reduction of separation anxiety, pain, and inflammation. The science behind these products involves over half a decade of clinical research in the field and lab work to provide accuracy in dosage and delivery of optimal absorption per serving. Safe Harbor Notice This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the company’s business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission. The company undertakes no obligation to update any forward-looking statements. Contact: For further investor and media information, contact:Endexx CorporationTodd DavisChairman & CEOEndexx@endexx.com 480-595-6900

Endexx Uses Collaboration to Build a Brand

At Benzinga's February Cannabis Capital Conference, Endexx (OTC: EDXC) CEO Todd Davis spoke about positioning, branding and the company's upcoming collaboration with DJ Khaled. Endexx Corporation is a lifestyle company focused on the intersection of science, compliance and formulation of innovative phytonutrient-based food and nutritional products. Endexx, through its operating division CBD Unlimited, develops and distributes all-natural CBD products derived from cannabis sativa plant (hemp), containing less than 0.01% THC. Its products range from oils, capsules, topicals, and pet products, all with the shared purpose of therapeutic and pain relief for humans and pets. PhytoBites are CBD soft chews for animal use that are formulated to promote health and support the reduction of separation anxiety, pain and inflammation. The science behind these products involves over half a decade of clinical research in the field and lab work to protect the accuracy in dosage and delivery of absorption per each serving. The Power of Collaboration Endexx has structured itself as a collaboration corporation that provides a platform for entrepreneurs to thrive by giving them ownership as shareholders. One of the company's most anticipated new partnerships is with DJ Khaled. "He has a passion for this [cannabis] and is evolving into a family man," Davis highlighted. The music sensation now owns 25% of a Joint Venture LLC with Endexx and will have several unique CBD wellness products hitting the market in the second quarter. "His products tested very well and we're anticipating huge success with this line. We really feel that it's going to create its own market and set us apart," Davis praised. Becoming a Brand The company is also preparing for a nationwide rollout in the next 12 to 18 months, expecting to be in 40 to 45 states and 100,000 new stores. The Endexx management team and its advisory group each have at minimum 10 to 50 years of experience in their respective fields. Davis explained that the company, which launched in early 2014, spent its first 5 years positioning itself to prepare for this current moment of acceleration. "We took the time to know our consumers and let the market grow. We're now up to 6,000 stores nationwide and that's without even putting our foot on the gas," Davis stated. "We used the downtime in 2020 to reposition our brand." Endexx has access to nearly 1 million stores, 150,000 of which it plans to target within the next 3 years. Pet Approved Endexx currently operates under the brand CBD Unlimited, which has begun to offer wellness products for animals. "Pets don't lie," Davis commented. "We've seen changes in behavior and increased mobility. From early testing, it [CBD products for pets] stood out, for dogs especially. It improves the quality of life for puppies, nervous nellies or end-of-life care for senior dogs." The company's animal science team has even begun working on a delivery system for horses with hopes that CBD could reach beyond the common house pet. "All mammals can benefit from this one way or another," Davis encouraged. Endexx Corporation is a micro-cap, publicly-traded company, representing the interests of its shareholders and collaborating with independent software developers, scientists, engineers and other companies to build businesses that can thrive collectively in the equity markets. Visit https://www.endexx.com/ for more info. See more from BenzingaClick here for options trades from BenzingaZuber Lawler's Assessment and Advice on Consolidation at Benzinga's Cannabis Capital ConferenceAyr Wellness Talks About the Importance of Cultivation and Access at Benzinga's Cannabis Capital Conference© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Endexx Files Form 10 Registration Statement for SEC Review

CAVE CREEK, AZ, March 05, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Endexx Corporation (OTC: EDXC), a lifestyle company focused on the intersection of science, compliance, and formulation of innovative phytonutrient-based food and nutritional products, today announced that it has publicly filed its Registration Statement on Form 10 with the Securities and Exchange Commission (SEC). This is a voluntary filing that is subject to SEC review. If the Registration Statement becomes effective, it would designate Endexx as an SEC reporting company and register the class of its shares of common stock pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended (the Exchange Act). Additionally, if the Registration Statement become effective, investors, who purchased or purchase shares of the Company’s common stock through private placements, would be permitted to resell their shares into the public markets pursuant to the exemption from registration under Rule 144 of the Securities Act of 1933, as amended, subject to compliance with the Rule’s provisions. Endexx currently publishes quarterly and annual reports, which include its financial statements, and is in compliance with the OTC Markets Group’s Alternative Reporting Standards. If the Registration Statement becomes effective, Endexx would file these reports and financial statements in the form of 10-Qs and 10-Ks with the SEC, along with Current Reports on Form 8-K, in addition to complying with its other obligations under the Exchange Act. See Filing: https://sec.report/Document/0001493152-21-005346/ About Endexx Corporation Endexx Corporation, through its operating subsidiary CBD Unlimited, develops and distributes all-natural CBD products derived from cannabis sativa plant (Hemp), containing less than 0.01% THC. Its products range from oils, capsules, topicals, and pet products, all with the shared purpose of therapeutic and pain relief for humans and pets. Phyto-Bites are CBD soft chews for animal use that are formulated to promote health and support the reduction of separation anxiety, pain, and inflammation. The science behind these products involves over half a decade of clinical research in the field and lab-work to provide accuracy in dosage and delivery of optimal absorption per serving. Safe Harbor Notice This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the company’s business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company’s periodic filings with the OTC Markets Group’s and the Company’s Form 10 filed with the SEC. The company undertakes no obligation to update any forward-looking statements. Contact: For further investor and media information, contact: Endexx Corporation Todd Davis Chairman & CEO Endexx@endexx.com 480-595-6900

Endexx Corporation Announces Participation in the Benzinga Virtual Cannabis Capital Conference

Cave Creek, AZ, Feb. 24, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Endexx Corporation (OTC PINK:EDXC) will be presenting at the Benzinga Cannabis Capital Conference taking place on February 25-26, 2021 at 1:50 pm EST/11:50 am MST. We invite our shareholders to sign up to get a free spectator pass for the event: https://events.benzinga.com/ccc-free-registration About Benzinga Cannabis Capital Conference Benzinga's virtual Cannabis Capital Conference is guaranteed to offer participants all the benefits of an immersive and robust in-person conference from any remote location. The conference will feature an interactive forum of live presentations from top CEOs, investors, and leaders in the cannabis space. Don't miss this opportunity to connect with THE cannabis movers and shakers from across the globe. For more information and/or to register for the conference please visit: https://events.benzinga.com/ccc-free-registration We look forward to seeing you there. About Endexx Corporation Endexx Corporation, through its operating division CBD Unlimited, develops and distributes all-natural CBD products derived from cannabis sativa plant (Hemp), containing less than 0.01% THC. Its products range from oils, capsules, topicals, and pet products, all with the shared purpose of therapeutic and pain relief for humans and pets. Phyto-Bites are CBD soft chews for animal use that are formulated to promote health and support the reduction of separation anxiety, pain, and inflammation. The science behind these products involves over half a decade of clinical research in the field and lab work to provide accuracy in dosage and delivery of optimal absorption per serving. Endexx Corporation Todd Davis 4805956900 endexx@endexx.com www.endexx.com

Endexx Announces Fiscal Year-End Financial Results; Year Over Year Revenues Grow 79 Percent

Endexx launches 2021 with Accelerated Contract Revenue CAVE CREEK, AZ, Jan. 26, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Endexx Corporation (OTC: EDXC), a lifestyle company focused on the intersection of science, compliance, and formulation of innovative phytonutrient-based food and nutritional products, today announced its fiscal 2020 annual report. Endexx is pleased to report record revenue $1.97 million with growth of 78 percent year over year. The company generated its first gross profit on an annual basis in fiscal 2020. 2020 Milestones and Highlights: Joint Venture • Endexx signs contract with DJ Khaled to launch new CBD Brand and Category International Expansion · Cleared to Distribute CBD Products in Guam. · Jamaica’s CLA grants provisional licenses for Retail and Cultivation. Increased Distribution Reach · Endexx secured a Master Distribution contract with the leading distributor in North America. · Distribution contract provides access to over 1,000,000 stores in the United States. Product Innovation · Endexx launches new “Value Line” in December to reach wider audience with more accessible price point options. · Endexx creates five unique products to be sold at counter as a POP Impulse buy. · Endexx rebranded its Premium line. Acquisitions • Endexx acquired Kush Inc. (Kushwear Brands) • Endexx acquired CBD Life Brands (Nero Water) • Endexx acquired Retail Pro Associates (Ronald Cotting and Stephen Herron) “Even in light of the most challenging year ever for the company, the industry and the market, Endexx was able to survive and thrive in fiscal 2020,” stated CEO Todd Davis. Davis added, “Endexx is positioned to accelerate top line revenue growth exponentially in 2021. Covid 19 allowed us to rethink and reposition our company and its product lines to better meet the needs of its customers. We built new price point sensitive products and point of purchase impulse buy lines providing support to our sales and distribution partners. We secured the most dominant and widespread Master Distributor in the US. We then secured one of the single greatest influencers in the Music and Entertainment industry domestically and globally to both represent our products and collaborate to design a new category and market in the CBD Industry. Mr. DJ Khaled has partnered with Endexx to deliver the most exciting new wellness products in the Industry in 2021 and beyond. Adversity has brought our collective team together and has driven our focus on success and execution of our mission for years to come,” Davis concluded. www.endexx.com & www.cbdunlimited.com About Endexx Corporation Endexx Corporation, through its operating division CBD Unlimited, develops and distributes all-natural CBD products derived from cannabis sativa plant (Hemp), containing less than 0.01% THC. Its products range from oils, capsules, topicals, and pet products, all with the shared purpose of therapeutic and pain relief for humans and pets. Phyto-Bites are CBD soft chews for animal use that are formulated to promote health and support the reduction of separation anxiety, pain, and inflammation. The science behind these products involves over half a decade of clinical research in the field and lab work to provide accuracy in dosage and delivery of optimal absorption per serving. Safe Harbor Notice This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the company’s business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission. The company undertakes no obligation to update any forward-looking statements. Contact: For further investor and media information, contact: Endexx Corporation Todd Davis Chairman & CEO Endexx@endexx.com 480-595-6900